comparemela.com

Latest Breaking News On - Inhalation aerosol - Page 2 : comparemela.com

Bronchodilators Market Size, Share, Trends, Growth, Competitive Landscape and Forecast Period 2023-2030

According to the DataM market research report, the global bronchodilators market is growing at a CAGR of 3.8% over the forecast period 2023-2030

United statesAsia pacificSai kiranGlaxosmithkline plcMerck coSun pharmaceutical industries ltdAstrazeneca plcTeva pharmaceutical industries ltdPfizer incBoehringer ingelheim international gmbBayer agMajor companiesWorld health organizationDrug administrationGlenmark pharmaceuticalsMarket research

Lupin buys two inhalation brands from Sunovion Pharma for $75 M

To expand Lupin's portfolio of inhalation products in the US

Vinita guptaSunovion pharmaceuticals incInhalation solutionInhalation aerosolSunovion pharmaceuticals

Lupin signs agreement to acquire Two Inhalation Brands from Sunovion

Lupin has announced signing of an agreement to acquire all rights to two inhalation medicines, Brovana® Inhalation Solution and Xopenex HFA® Inhalation Aerosol, from Sunovion Pharmaceuticals Inc. for a purchase price of $75 million.

Vinita guptaLupin limitedSunovion pharmaceuticals incTwo inhalation brandsInhalation solutionInhalation aerosolSunovion pharmaceuticals

Lupin-led arm to acquire Sunovion Pharma s Brovana and Xopenex HFA brands

The acquisition of said brands will expand Lupin’s portfolio of Inhalation products.

United statesVinita guptaLupin incLupin limitedArformoterol tartrateInhalation solutionLevalbuterol tartrateInhalation aerosol

Lupin buys two inhalation brands from Sunovion Pharma for $75 M

To expand Lupin's portfolio of inhalation products in the US

Vinita guptaSunovion pharmaceuticals incInhalation solutionInhalation aerosolSunovion pharmaceuticals

vimarsana © 2020. All Rights Reserved.